BSX vs. DXCM: Boston Scientific vs. DexCom Stock Comparison
How do Boston Scientific (BSX) and DexCom (DXCM) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Boston Scientific (BSX) and DexCom (DXCM) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | BSX | DXCM |
|---|---|---|
| Name | Boston Scientific Corp. | DexCom Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 61.96 billion USD | 29.62 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | May 19, 1992 | April 14, 2005 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BSX | DXCM |
|---|---|---|
| Total Return (1Y) | -55.98% | 46.33% |
| Total Return (3Y, Annualized) | -5.05% | -4.50% |
| Total Return (5Y, Annualized) | 0.57% | -12.76% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
DexCom (DXCM) has an aggressive beta of 1.43, indicating higher sensitivity to broad-market moves, while Boston Scientific (BSX) is defensive at 0.57 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.
| Metric | BSX | DXCM |
|---|---|---|
| Volatility (1Y, Annualized) | 40.16% | 38.37% |
| Beta (5Y) | 0.57 | 1.43 |
| Max Drawdown (5Y) | -61.55% | -66.32% |
| Avg. Volume (3M) | 19.73M | 4.34M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BSX | DXCM |
|---|---|---|
| Sharpe Ratio (1Y) | -1.50 | 1.10 |
| Sortino Ratio (1Y) | -1.80 | 1.79 |
Profitability
ROE (TTM)
DexCom (DXCM) at 37.67% sits in the top ROE quartile, while Boston Scientific (BSX) at 14.12% is closer to the peer norm — stronger capital efficiency for DXCM.
BSX
Health Care Equipment & Services industry group
14.12%
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
DXCM
Health Care Equipment & Services industry group
37.67%
- Max
- 47.61%
- DXCM
- 37.67%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Boston Scientific (BSX) at 16.62% and DexCom (DXCM) at 19.42% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
BSX
Health Care Equipment & Services industry group
16.62%
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
DXCM
Health Care Equipment & Services industry group
19.42%
- Max
- 29.35%
- DXCM
- 19.42%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Boston Scientific (BSX) at 19.05% and DexCom (DXCM) at 24.34% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
BSX
Health Care Equipment & Services industry group
19.05%
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
DXCM
Health Care Equipment & Services industry group
24.34%
- Max
- 35.43%
- DXCM
- 24.34%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BSX | DXCM |
|---|---|---|
| ROE (TTM) | 14.12% | 37.67% |
| ROA (TTM) | 5.87% | 11.14% |
| Net Margin (TTM) | 16.62% | 19.42% |
| Operating Margin (TTM) | 19.05% | 24.34% |
| Gross Margin (TTM) | 67.98% | 63.42% |
Growth
Revenue Growth
Both Boston Scientific (BSX) at 19.87% and DexCom (DXCM) at 15.60% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Both Boston Scientific (BSX) at 55.20% and DexCom (DXCM) at 47.18% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.
Growth Metrics
| Metric | BSX | DXCM |
|---|---|---|
| Revenue Growth (YoY) | 19.87% | 15.60% |
| Revenue Growth (3Y CAGR) | 16.54% | 17.01% |
| EPS Growth (YoY) | 55.20% | 47.18% |
| EPS Growth (3Y CAGR) | 62.75% | 36.60% |
Financial Strength
Current Ratio (MRQ)
DexCom (DXCM) at 1.74 keeps current ratio within its industry’s typical mid-range, while Boston Scientific (BSX) at 1.37 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for BSX.
BSX
Health Care Equipment & Services industry group
1.37
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
DXCM
Health Care Equipment & Services industry group
1.74
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DXCM
- 1.74
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Boston Scientific (BSX) at 0.46 and DexCom (DXCM) at 0.55 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
BSX
Health Care Equipment & Services industry group
0.46
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
DXCM
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- DXCM
- 0.55
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | BSX | DXCM |
|---|---|---|
| Current Ratio (MRQ) | 1.37 | 1.74 |
| Debt / Equity (MRQ) | 0.46 | 0.55 |
| Net Debt / EBITDA | 2.04 | -0.28 |
Dividends
Dividend Yield (TTM)
Neither Boston Scientific (BSX) nor DexCom (DXCM) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Boston Scientific (BSX) nor DexCom (DXCM) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BSX | DXCM |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Boston Scientific (BSX) at 18.04 sits in the cheaper P/E ratio quartile, while DexCom (DXCM) at 31.26 is closer to its industry’s usual earnings multiple — a discount for BSX, though growth and earnings durability still matter.
BSX
Health Care Equipment & Services industry group
18.04
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
DXCM
Health Care Equipment & Services industry group
31.26
- Max
- 80.41
- Q3
- 47.62
- DXCM
- 31.26
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Boston Scientific (BSX) at 2.94 is priced about in line with its industry on P/S ratio, while DexCom (DXCM) at 5.80 sits in the pricier quartile — DXCM costs more per dollar of sales.
BSX
Health Care Equipment & Services industry group
2.94
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
DXCM
Health Care Equipment & Services industry group
5.80
- Max
- 8.80
- DXCM
- 5.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Boston Scientific (BSX) at 2.42 is valued about in line with its industry on P/B ratio, while DexCom (DXCM) at 11.68 carries an above-peer premium to book — DXCM is pricier on assets.
BSX
Health Care Equipment & Services industry group
2.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
DXCM
Health Care Equipment & Services industry group
11.68
- DXCM
- 11.68
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | BSX | DXCM |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | 31.26 |
| P/S Ratio (TTM) | 2.94 | 5.80 |
| P/B Ratio (MRQ) | 2.42 | 11.68 |
| Free Cash Flow Yield (TTM) | 4.02% | 2.74% |